From: Adult onset Still’s disease in the elderly: a case-based literature review
Clinical Characteristics | Total (N, %)a | Patients with MASb (N, row %) | Patients without MAS (N, row %) | p-value* |
---|---|---|---|---|
Patient count | 42 (100%) | 10 (23.81%) | 32 (76.19%) | |
AGE (YEAR), (MEDIAN, IQR) | 75, 7 | 74.5, 8 | 75, 6 | 0.49 |
Female | 34 (80.95%) | 10 (23.81%) | 24 (57.14%) | 0.16 |
Fever | 42 (100%) | 10 (23.81%) | 32 76.19%) | 1.00 |
Rash | 34 (80.95%) | 10 (23.81%) | 24 (57.14%) | 0.16 |
Pruritic rash | 9 (21.43%) | 4 (9.52%) | 5 (11.90%) | 0.23 |
Arthralgia/Myalgia | 38 (90.48%) | 7 (16.67%) | 31 (73.81%) | 0.04 |
Serositis | 7 (16.67%) | 1 (2.38%) | 6 (14.29%) | 0.49 |
Hepatosplenomegaly | 14 (33.33%) | 3 (7.14%) | 11 26.19%) | 0.06 |
Sore throat | 22 (52.38%) | 6 (14.29%) | 16 (38.10%) | 0.31 |
Leukocytosis, (Median, IQR) | 13,700, 8800 | 9000, 5895 | 16,000, 9470 | < 0.01 |
Hyperferritinemia, (Median ± IQR) | 5336, 15,447 | 41,932, 70,250 | 2684, 7821 | < 0.01 |
Transaminitis | 28 (66.67%) | 7 (16.67%) | 21 (50.0%) | 1.00 |
Delayed Diagnosis (> 1 month) | 38 (90.48%) | 9 (21.43%) | 29 (69.05%) | < 0.01 |
Corticosteroids | 39 (92.36%) | 9 (21.43%) | 30 (71.43%) | 0.28 |
NSAIDsc | 14 (33.33%) | 1 (2.38%) | 13 (30.95%) | 0.04 |
Conventional DMARDsd | 17 (40.48%) | 5 (11.90%) | 12 (28.57%) | 0.15 |
Biologic DMARDs | 8 (19.05%) | 3 (7.14%) | 5 (11.90%) | 0.09 |
Miscellaneous Treatment | 8 (19.05%) | 3 (7.14%) | 5 (11.90%) | 0.09 |